查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1961013

血管内超音波市场：市场洞察、竞争格局及至2034年的市场预测

Intravascular Ultrasound Market Insights, Competitive Landscape, and Market Forecast - 2034
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

血管内超音波市场概述

  • 全球血管内超音波市场规模预计将从 2025 年的 9.2694 亿美元增长到 2034 年的 17.7419 亿美元，展现出强劲且持续的成长势头。
  • 全球血管内超音波市场预计在 2026 年至 2034 年的预测期内将以 7.52% 的复合年增长率成长。
  • 血管内超音波市场的主要驱动力是心血管疾病（CVD）盛行率的不断上升。人口老化、肥胖、糖尿病和高血压等风险因素显着增加了对血管内超音波（IVUS）作为重要诊断和治疗工具的需求。随着全球经皮冠状动脉介入治疗（PCI）数量的增加，IVUS正被广泛用于提高手术精准度、优化支架植入、减少血管再阻塞等併发症。此外，主要市场参与企业正透过策略性收购、伙伴关係和研发投资来加速成长，以开发高解析度成像、3D IVUS和人工智慧驱动的分析等先进的IVUS技术。
  • 血管内超音波市场的主要企业包括 Koninklijke Philips NV、Boston Scientific Corporation、Terumo Corporation、NIPRO、CONAVI MEDICAL、Bracco、Intravascular Imaging Incorporated (i3)、Insight Lifetech Co., Ltd.、上海脉搏医疗科技有限公司、MicroPort Scientific Corporation 有限公司。
  • 由于心血管疾病及其危险因子病例不断增加，预计北美将引领整个血管内超音波市场的发展。此外，该地区血管成形术数量的增加也进一步推动了血管内超音波市场的扩张。
  • 按类型划分，血管内超音波市场中，预计到 2025 年， IVUS导管类别将占据最大的市场份额。

推动血管内超音波市场成长的因素

  • 心血管疾病及相关风险因素的增加推动了血管内超音波需求的激增：心血管疾病 (CVD) 及高血压、糖尿病、肥胖等相关风险因素的增加，以及人口老化，正在显着推动血管内超音波(IVUS) 系统市场的整体成长。
  • 经皮冠状动脉介入治疗（PCI）的快速成长正在推动血管内超音波市场的发展：经经皮冠状动脉介入治疗（PCI）的快速成长正在推动血管内超音波（IVUS）市场的成长，而血管内超音波（IVUS）的日益普及是推动这一成长的主要因素。由于PCI手术具有微创、恢復时间短、手术风险低等治疗方法，与传统的冠状动脉绕道手术手术（CABG）相比，PCI手术（如血管成形术和支架置入术）已成为冠状动脉疾病（CAD）的首选治疗方法。
  • 主要市场参与企业在收购、合作和研发等策略活动方面激增：在全球范围内拓展产品开发活动是血管内超音波市场蓬勃发展的基础。技术进步、疾病适应症的扩展、核准审批和策略合作正在推动创新诊断解决方案的诞生。随着持续的投资和创新，血管内超音波有望透过为多种疾病提供非侵入性、精准且个人化的诊断工具，从而变革医疗保健产业。

血管内超音波市场报告细分

本血管内超音波市场报告全面概​​述了全球血管内超音波市场，重点分析了关键趋势、成长要素、挑战和机会。报告按类型（IVUS导管和血管内主机）、应用（冠状动脉介入治疗和周边血管介入治疗）、终端用户（医院和诊所、诊断影像中心及其他机构）以及地区进行了详细的市场细分。本报告深入分析了北美、欧洲和亚太等主要市场的竞争格局、监管环境和市场动态，并详细介绍了主要行业参与企业和近期产品创新，为企业提供所需数据，帮助他们识别市场潜力、制定战略规划，并在快速增长的血管内超音波市场中把握新机会。

血管内超音波（IVUS）是一种介入性心臟病学中用于表征病变形态、量化斑块负荷、指导支架尺寸、评估支架扩张和识别手术併发症的侵入性、基于导管的成像方式。

血管内超音波市场的主要驱动力是心血管疾病（CVD）盛行率的不断上升。人口老化、肥胖、糖尿病和高血压等风险因素显着增加了对血管内超音波（IVUS）的需求，使其成为重要的诊断和介入工具。随着全球经皮冠状动脉介入治疗（PCI）数量的不断增加，IVUS 被广泛用于提高手术精准度、优化支架植入以及减少血管再阻塞等併发症。此外，主要市场参与企业正透过策略性收购、伙伴关係和研发投资来加速成长，以开发高解析度成像、3D IVUS 和人工智慧驱动的分析等先进的 IVUS 技术。

血管内超音波市场的最新市场动态和趋势是什么？

近年来，全球血管内超音波市场经历了显着增长，这主要是由于心血管疾病 (CVD) 及其相关危险因子的盛行率不断上升，经经皮冠状动脉介入治疗 (PCI) 的激增带动了血管内超音波(IVUS) 的日益普及，以及主要市场参与企业产品开发活动的增加。

根据世界心臟联盟（2024）的数据，心房颤动是最常见的心律不整类型，影响约6,000万人。心房颤动会增加血栓、心臟衰竭和中风的风险。此外，据同一资讯来源称，心房颤动患者发生中风的几率是普通人的五倍。

心房颤动是最常见的心律不整，与血栓性栓塞症、中风和结构性心臟併发症的风险增加有关。随着肺静脉阻塞（PVI）、左心耳封堵（LAA）和心房颤动消融术等导管介入治疗在心房颤动治疗中日益重要，血管内超音波（IVUS）透过提供血管结构的即时高解析度影像，在指导这些手术中发挥关键作用，从而推动了整个IVUS市场的发展。

根据英国心臟基金会（2024年）的最新数据，全球约有5,600万名女性和4,500万名男性中风倖存者。据估计，全球至少有1,300万人患有先天性心臟疾病，另有数百万名患者尚未确诊。接受过手术矫正的先天性心臟疾病患者通常需要长期监测和干预，而血管内超音波（IVUS）作为一种微创诊断工具，可用于评估移植血管的通畅性、评估血管重塑情况以及检测术后併发症。

此外，根据密西根大学（2024 年）的数据，超过 50 万美国人接受了经皮冠状动脉介入治疗 (PCI)，这是一种微创手术，用于清除为心臟供血的动脉中的阻塞物。

随着经皮冠状动脉介入治疗方法（PCI）成为冠状动脉疾病（CAD）的主要治疗方法，介入性心臟科医师越来越依赖血管内超音波（IVUS）来改善手术效果。与传统血管造影术不同，IVUS 可提供即时、高解析度的横断面影像，从而实现精确的血管评估、斑块分析和最佳支架置入。这促使 IVUS 的应用日益广泛，提高了 PCI 的成功率并减少了併发症，进而推动了市场需求。

因此，血管内超音波（IVUS）的发展与每年经皮冠状动脉介入治疗（PCI）手术的数量以及IVUS在支架植入前后应用中的日益普及密切相关。例如，波士顿科学公司提供的OPTICROSS™高清冠状动脉成像导管可提供高画质影像，以辅助精准的支架植入和手术效果评估。此外，该公司的AVVIGO™+多重模式引导系统将IVUS与血流储备分数（FFR）功能相结合，以增强PCI术中的血管成像和生理评估。

此外，产品研发活动的增加也进一步推动了血管内超音波（IVUS）市场的整体发展。例如，2025年3月，波士顿科学公司宣布已签署最终协议，收购SoniVie有限公司，这是一家开发TIVUS™血管内超音波系统的私人公司。

因此，预计上述因素将在 2020 年至 2034 年的预测期内推动血管内超音波市场的整体发展。

然而，IVUS导管在插入、操作或拔出过程中可能会对动脉壁造成机械性损伤，进而导致血管撕裂。此外，光同调断层扫瞄（OCT）和先进血管造影术等替代技术的出现，可能会在预测期内限制IVUS的市场发展。

血管内超音波市场細項分析

血管内超音波市场：按类型（IVUS导管和IVUS主机）、按应用（冠状动脉介入治疗和周边血管介入治疗）、按最终用户（医院和诊所、诊断影像中心、其他）和按地区（北美、欧洲、亚太地区、世界其他地区）划分

血管内超音波市场区域分析

北美血管内超音波市场趋势

预计到2025年，北美将占据血管内超音波市场所有地区中最高的份额，达到43.72%。这一主导地位主要归因于心血管疾病及其危险因子病例的不断增加。此外，全部区域血管成形术数量的成长也进一步推动了血管内超音波市场的扩张。

根据美国疾病管制与预防中心（CDC）发布的最新数据，2022年约有4.8%的成年人被诊断出患有心臟疾病（CHD）。冠心病患者会出现动脉粥状硬化，导致血流受限，增加心肌梗塞的风险。随着冠心病病例的增加，对血管内超音波（IVUS）等先进影像诊断技术的需求也随之增长，从而推动了市场发展。

此外，根据美国疾病管制与预防中心（CDC，2024）的数据，2021年至2023年间，成人肥胖盛行率为40.3%。超重会导致代谢异常，加速斑块积聚，并增加经皮冠状动脉介入治疗（PCI）的需求。因此，血管经皮超音波（IVUS）在指导支架置入和优化治疗方面发挥关键作用，从而推动了市场成长。

此外，根据密西根大学（2025年）的数据，美国每年进行超过一百万例血管成形术。在血管成形术中，血管内超音波（IVUS）可以帮助准确评估斑块和病变特征，并指导支架的放置和扩张。因此，预计该地区血管内超音波的应用将会成长。

预计这些因素将在预测期内推动美国血管内超音波市场的成长。

欧洲血管内超音波市场趋势

在欧洲，心血管疾病和糖尿病、肥胖、高血压等危险因子的日益普遍，推动了全部区域内超音波市场的成长，从而刺激了整个血管内超音波市场的扩张。

根据英国心臟基金会的数据，到 2024 年，将有 760 万人患有心臟和循环系统疾病。动脉硬化、心肌梗塞和中风等疾病的发病率不断上升，推动了对血管内超音波(IVUS) 等先进诊断工具的需求，IVUS 可提供冠状动脉的即时影像，并有助于评估斑块积聚、血管直径和支架放置情况。

此外，根据英国糖尿病协会（2024 年）的数据，2023-2024 年英国约有 580 万人患有糖尿病。

此外，英国政府（2024 年）的数据显示，18 岁及以上成年人中有 63.8% 超重或肥胖。

此外，根据英国心臟基金会（2025年）的统计数据，英国有500万成年人患有未确诊的高血压。糖尿病、肥胖和高血压等危险因子的日益普遍，正推动着血管内超音波（IVUS）引导手术的普及，以期改善手术效果、减少术后併发症并提高患者的长期存活率。

因此，预计上述所有因素将在预测期内推动英国血管内超音波市场的成长。

亚太地区血管内超音波市场趋势

亚太地区预计在 2026 年至 2034 年的预测期内将以 8.86% 的健康复合年增长率增长，这主要得益于人口老龄化加剧以及心血管疾病和相关风险因素的日益普遍，从而成为血管内超音波市场的主要驱动力。

根据发表在 2024 年美国国家医学图书馆日誌的一项最新研究，据估计，中国平均约有 3.3 亿人患有心血管疾病 (CVD)。

其中，估计有 1,300 万例中风，1,140 万例型冠心病，500 万例肺因性心臟疾病，890 万例中风，1,140 万例心臟疾病，500 万例肺因性心臟病，890 万例先天性心臟衰竭，490 万例心臟疾病，250 万例风湿性心臟病，200 万例先天性心臟病，4,530 万例下肢动脉心臟疾病，以及 2.45 亿例高血压。

此外，根据国际糖尿病联盟糖尿病地图集（2024 年），预计到 2045 年，中国年龄调整后的相对盛行率（糖尿病）将上升至 12.6%。

由于这些疾病通常伴随着复杂的动脉阻塞和动脉粥样硬化，血管内超音波(IVUS) 在提供血管的高解析度即时影像方面发挥着至关重要的作用，使心臟病专家能够准确评估斑块负荷、血管大小和病变特征，从而透过优化支架放置和减少血管再阻塞和支架血栓症等併发症来提高经皮冠状动脉介入治疗 (PCI) 的准确性，进而整个血管内生长(IVUS) 推动的准确性，进而整个血管超音波(IVUS)。

血管内超音波市场的主要企业有哪些？

以下列出了血管内超音波市场的主要企业，它们合计占据最大的市场份额，并主导行业趋势：

  • Koninklijke Philips NV
  • Boston Scientific Corporation
  • Terumo Corporation
  • NIPRO
  • CONAVI MEDICAL
  • Bracco
  • Intravascular Imaging Incorporated (i3)
  • Insight Lifetech Co., Ltd.
  • Shanghai Pulse Medical Technology Inc.
  • MicroPort Scientific Corporation
  • Provisio Medical, Inc.
  • 其他的

血管内超音波（IVUS）市场的竞争格局正在发生怎样的变化？

血管内超音波（IVUS）市场竞争格局高度集中，主要由少数几家全球医疗技术领导企业主导，包括波士顿科学、飞利浦医疗保健、泰尔茂和美敦力。这些公司凭藉其在导管检查室的强大影响力、丰富的成像产品组合以及长期以来赢得的临床医生信任，占据了超过一半的市场份额。这些公司透过持续的产品创新、人工智慧驱动的成像增强、与介入平台的整合以及策略收购来塑造竞争格​​局，从而提高了新进入者的准入门槛。同时，中小型的利基公司则专注于差异化的导管技术、混合成像或针对特定地区（尤其是新兴市场）量身定制的高性价比解决方案，展开竞争。因此，儘管大型企业保持定价权和规模优势，但持续的技术进步和对精准引导介入治疗的临床需求，使得市场保持竞争态势，并未出现完全整合。

血管内超音波市场最新趋势

  • 2025 年 3 月，波士顿科学公司宣布已签署最终协议，收购 SoniVie Ltd.，这是一家开发 TIVUS™ 血管内超音波系统的私人公司。
  • 2024 年 10 月，MicroPort Scientific, Inc. 的子公司 MicroPort Microimaging 获得了国家药品监督管理局 (NMPA) 对其 Decypher™ IVUS 诊断系统和 Outsight® 一次性 IVUS 诊断导管的上市核准。
  • 2024 年 5 月，Provisio Medical, Inc. 宣布完成了使用 Provisio™ SLT IVUS™ 系统的第一个商业性临床案例。
  • 2024年4月，Provisio Medical公司的Provisio™ SLT IVUS™系统获得FDA 510(k)认证，该系统引入了声波管腔断层扫描（SLT）技术，无需复杂的影像解读即可实现即时、自动化的血管管腔测量。它是首个整合血管内成像和支援导管的系统，透过同时提供管腔测量、可视化、导管导引线支撑和造影输送，增强了血管内手术的效率。
  • 2023 年 10 月，Evident Vascular 结束了隐密模式，获得了 3,500 万美元的 A资金筹措，用于开发其血管内成像平台。

影响分析

人工智慧驱动的创新与应用：

人工智慧在血管内超音波（IVUS）领域的创新和应用正在迅速改变血管内超音波的性能和解读方式，使这项技术从人工图像阅片发展到自动化、数据驱动的临床决策支援。最新的人工智慧演算法，特别是深度学习模型，已被开发出来，能够高精度地自动分割管腔、血管壁、斑块和支架结构，从而显着减少IVUS解读过程中人工标註的需求和操作者之间的差异。这些模型可以辅助对血管成分（例如钙化和狭窄管腔）进行分类，量化关键解剖标誌，并进行病变特征分析，有助于提高诊断的一致性和治疗计划的发展。人工智慧也被用来预测手术结果（例如旋切动脉粥状硬化斑块切除术的影响程度）。透过将IVUS影像与临床和人口统计资料结合，人工智慧有望应用于更广泛的不利事件风险预测模型。除了直接的临床解读之外，人工智慧也正在加速临床医生的培训和技能提升。例如，我们基于人工智慧的自适应教育平台提供个人化的、基于案例的血管内超音波（IVUS）学习路径，能够更有效地培养模式识别和决策能力。这些创新旨在提高工作流程效率，规范影像分析，并扩大血管内超音波在介入心臟病学中的效用和普及程度。

美国关税对血管内超音波市场的影响分析：

美国对血管内超音波（IVUS）市场征收关税的影响，反映了近期旨在将製造业迁回国内、减少对海外供应链依赖的关税政策给整个美国医疗设备行业带来的更广泛压力。根据新的贸易措施，进口医疗设备和组件（包括诊断和影像设备）将被征收高达两位数的关税，这显着增加了来自中国、欧盟和其他地区的产品的製造和采购成本——而这些地区正是IVUS等先进心血管技术的关键供应来源。关税的提高正在挤压美国和国际IVUS製造商的利润空间。製造商被迫将成本转嫁给医院和医疗保健机构，或自行承担更高的投入成本，这可能会在成本敏感的环境下减缓IVUS的普及应用，并推迟成像技术的升级。关税造成的供应链中断正在降低长期存在的全球生产网络的效率，促使一些公司考虑将生产迁回国内或实现供应来源多元化。然而，由于需要获得监管部门的核准以及对生产设施进行改造，这些转型既耗时又昂贵。最终，关税带来的成本增加和不确定性可能导致价格上涨，给医疗服务提供者的采购带来挑战，并限制对尖端成像技术的需求，从而限制美国血管内超音波（IVUS）市场的成长，除非针对关键医疗技术实施政策调整和关税豁免。

这项分析如何帮助客户

  • 成本管理：了解关税环境可以让客户预测成本成长并据此调整定价策略，从而确保盈利。
  • 供应链优化：寻找替代采购来源并实现供应链多元化可以减少对高关税地区的依赖，并提高韧性。
  • 监管：专家指导客户应对不断变化的法规环境，帮助客户保持合规并避免潜在的法律挑战。
  • 策略规划：深入了解关税的影响，可以就製造地、伙伴关係和打入市场策略做出明智的决策。

目录

第一章 血管内超音波市场报告概述

2. 血管内超音波市场执行摘要

  • 市场概览

第三章：血管内超音波市场关键因素分析

  • 血管内超音波市场驱动因素
  • 血管内超音波市场限制与挑战
  • 血管内超音波市场机会

第四章 影响分析

  • 人工智慧驱动的创新和应用
  • 美国关税的影响分析

第五章 监理分析

  • 我们
  • 欧洲
  • 日本
  • 中国

6. 血管内超音波市场的波特五力分析

第七章 血管内超音波市场估值

  • 按类型
    • IVUS导管
    • IVUS主机
  • 透过使用
    • 冠状动脉介入治疗
    • 週边干预
  • 最终用户
    • 医院和诊所
    • 诊断影像中心
    • 其他的
  • 按地区
    • 北美洲
    • 欧洲
    • 亚太地区
    • 其他地区

第八章 竞争情势

第九章Start-Ups资金筹措与投资趋势

10. 血管内超音波市场公司及产品概况

  • Koninklijke Philips NV
  • Boston Scientific Corporation
  • Terumo Corporation
  • NIPRO
  • CONAVI MEDICAL
  • Bracco
  • Intravascular Imaging Incorporated (i3)
  • Insight Lifetech Co., Ltd.
  • Shanghai Pulse Medical Technology Inc.
  • MicroPort Scientific Corporation
  • Provisio Medical, Inc.

第十一章：KOL视角

第十二章计划方法

第十三章：关于 DelveInsight

第十四章 免责声明和联络我们

Product Code: DIMDCL0441

Intravascular Ultrasound Market Summary

  • The global intravascular ultrasound market is expected to increase from USD 926.94 million in 2025 to USD 1,774.19 million by 2034, reflecting strong and sustained growth.
  • The global intravascular ultrasound market is growing at a CAGR of 7.52% during the forecast period from 2026 to 2034.
  • The market of intravascular ultrasound is being primarily driven by the rising prevalence of cardiovascular diseases (CVDs), driven by risk factors such as aging populations, obesity, diabetes, and hypertension, is significantly boosting the demand for intravascular ultrasound (IVUS) as an essential diagnostic and interventional tool. With the increasing number of percutaneous coronary interventions (PCI) globally, IVUS is being widely adopted to enhance procedural precision, optimize stent deployment, and reduce complications such as restenosis. Additionally, key market players are accelerating growth through strategic acquisitions, partnerships, and R&D investments to develop advanced IVUS technologies, such as high-resolution imaging, 3D IVUS, and AI-driven analysis.
  • The leading companies operating in the intravascular ultrasound market include Koninklijke Philips N.V., Boston Scientific Corporation, Terumo Corporation, NIPRO, CONAVI MEDICAL, Bracco, Intravascular Imaging Incorporated (i3), Insight Lifetech Co., Ltd., Shanghai Pulse Medical Technology Inc., MicroPort Scientific Corporation, Provisio Medical, Inc., and others.
  • North America is expected to dominate the overall intravascular ultrasound market due to the rising cases of cardiovascular disorders and its risk factors. Additionally, the increasing number of angioplasty procedures across the region is further escalating the market of IVUS.
  • In the type segment of the intravascular ultrasound market, the IVUS catheters category is estimated to account for the largest market share in 2025.

Factors Contributing to the Growth of the Intravascular Ultrasound Market

  • Rising prevalence of cardiovascular diseases and associated risk factors leading to a surge in intravascular ultrasound: The rising prevalence of cardiovascular diseases (CVDs) and associated risk factors such as hypertension, diabetes, obesity, and an aging population is significantly boosting the overall market for Intravascular Ultrasound (IVUS) systems.
  • The expanding use of IVUS due to the surge in percutaneous coronary interventions (PCI) esclating the market of intravascular ultrasound: The expanding use of Intravascular Ultrasound (IVUS) due to the surge in percutaneous coronary interventions (PCI) is significantly driving the growth of the IVUS market. PCI procedures, such as angioplasty and stent placement, have become the preferred treatment option for coronary artery disease (CAD) due to their minimally invasive nature, reduced recovery time, and lower procedural risks compared to traditional coronary artery bypass grafting (CABG).
  • Surging strategic activities such as acquisitions, partnerships, R&D, and others by key market players: The growing product development activities across the globe are a cornerstone of the booming intravascular ultrasound market. Advances in technology, expanding disease applications, approvals, and strategic collaborations are enabling the creation of innovative diagnostic solutions. With continued investment and innovation, intravascular ultrasound are set to transform healthcare by offering non-invasive, accurate, and personalized diagnostic tools for a wide range of diseases.

Intravascular Ultrasound Market Report Segmentation

This intravascular ultrasound market report offers a comprehensive overview of the global Intravascular Ultrasound market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Type (IVUS Catheters and IVUS Consoles), Application (Coronary Interventions and Peripheral Interventions), End-Users (Hospitals and Clinics, Diagnostic Imaging Centers, and Others), and geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing intravascular ultrasound market.

Intravascular ultrasound (IVUS), a catheter-based invasive imaging modality has applications in interventional cardiology for the characterization of lesion morphology, quantification of plaque burden, stent size guidance, assessment of stent expansion, and in identification of procedural complications.

The market of intravascular ultrasound is being primarily driven by the rising prevalence of cardiovascular diseases (CVDs), driven by risk factors such as aging populations, obesity, diabetes, and hypertension, is significantly boosting the demand for intravascular ultrasound (IVUS) as an essential diagnostic and interventional tool. With the increasing number of percutaneous coronary interventions (PCI) globally, IVUS is being widely adopted to enhance procedural precision, optimize stent deployment, and reduce complications such as restenosis. Additionally, key market players are accelerating growth through strategic acquisitions, partnerships, and R&D investments to develop advanced IVUS technologies, such as high-resolution imaging, 3D IVUS, and AI-driven analysis.

What are the latest intravascular ultrasound market dynamics and trends?

The global market for intravascular ultrasound has witnessed significant growth in recent years, largely driven by the rising prevalence of cardiovascular diseases (CVDs) and associated risk factors, the expanding use of Intravascular Ultrasound (IVUS) due to the surge in percutaneous coronary interventions (PCI), and increase in product development activities among the key market players.

According to the World Heart Federation (2024), approximately 60 million population was affected by atrial fibrillation which is one of the most common types of irregular heartbeat, or arrhythmia. It can increase the risk of blood clots, heart failure and stroke. Additionally, as per the same source people with atrial fibrillation were 5X times more likely to suffer a stroke.

Atrial fibrillation, the most common cardiac arrhythmia, is associated with a heightened risk of thromboembolic events, stroke, and structural heart complications. As AF management increasingly involves catheter-based interventions such as pulmonary vein isolation (PVI), left atrial appendage (LAA) closure, and atrial fibrillation ablation, IVUS plays a critical role in guiding these procedures by providing real-time, high-resolution imaging of vascular structures and thereby boosting the overall IUVS market.

According to a recent data provided by British Heart Foundation (2024), globally, around 56 million women and 45 million men were stroke survivors. It's estimated that at least 13 million people worldwide lived with congenital heart disease, with potentially millions more undiagnosed. Congenital heart disease patients who undergo surgical corrections often need long-term monitoring and intervention, where IVUS serves as a minimally invasive diagnostic tool to assess graft patency, evaluate vascular remodeling, and detect post-surgical complications.

Additionally, according to the data provided by the University of Michigan (2024), more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally invasive procedure to unclog the arteries that feed the heart.

As PCI becomes the primary treatment for CAD, interventional cardiologists increasingly rely on IVUS for enhanced procedural outcomes. Unlike traditional angiography, IVUS provides real-time, high-resolution cross-sectional imaging, enabling precise vessel assessment, plaque analysis, and optimal stent placement. This has driven higher IVUS adoption, improving PCI success rates and reducing complications, thereby boosting its market demand.

Thus, the growth of IUVS is closely linked to the annual volume of PCI procedures and the increasing integration of IVUS in both pre-stenting and post-stenting applications. For example, Boston Scientific offers the OPTICROSS(TM) HD Coronary Imaging Catheters, which provide high-definition imaging to assist in accurate stent placement and assessment of procedural results. Additionally, their AVVIGO(TM)+ Multi-Modality Guidance System integrates IVUS and Fractional Flow Reserve (FFR) capabilities, enhancing vessel imaging and physiological assessments during PCI.

Furthermore, the increase in product development activites are further boosting the overall market of IVUS. For instance, in March 2025, Boston Scientific Corporation announced it has entered into a definitive agreement to acquire SoniVie Ltd., a privately held medical device company that has developed the TIVUS(TM) Intravascular Ultrasound System.

Thus, the factors mentioned above are expected to boost the overall market of intravascular ultrasound during the forecast period from 202 to 2034.

However, IVUS catheter can sometimes cause mechanical trauma to the arterial wall during insertion, manipulation, or withdrawal lading to vessel dissection and presence of alternatives such as optical coherence tomography (OCT) and advanced angiography may limit the future market of IVUS during the forecast period.

Intravascular Ultrasound Market Segment Analysis

Intravascular Ultrasound Market by Type (IVUS Catheters and IVUS Consoles), Application (Coronary Interventions and Peripheral Interventions), End-Users (Hospitals and Clinics, Diagnostic Imaging Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Intravascular Ultrasound Market Regional Analysis

North America Intravascular Ultrasound Market Trends

North America is expected to account for the highest proportion of 43.72% of the Intravascular Ultrasound market in 2025, out of all regions. This domination is due to the rising cases of cardiovascular disorders and its risk factors. Additionally, the increasing number of angioplasty procedures across the region is further escalating the market of IVUS.

According to the recent data provided by Centre for Disease Control and Prevention (2024), in 2022, approximately 4.8% of adults have been diagnosed with coronary heart disease. Patients with CHD develop atherosclerosis, leading to restricted blood flow and a higher risk of heart attacks. As CHD cases rise, the demand for advanced imaging technologies like IVUS increases for diagnosis, thereby driving market growth.

Moreover, according to the data provided by the Centre for Disease Control and Prevention (2024), the prevalence of obesity among adults was 40.3% during 2021 to 2023. Excess weight leads to metabolic disorders, accelerating plaque buildup and increasing the need for PCI. Thus, IVUS plays a key role in guiding stent placement and optimizing treatment, thereby driving its market growth.

Additionally, according to the data provided by the University of Michigan (2025), angioplasty is done on more than a million people a year in the United States. During angioplasty, IVUS helps in accurate assess of plaque and lesion characteristics, guide stent placement and expansion as a result, IVUS adoption is expected to escalate in the region.

Thus, all the above-mentioned factors are anticipated to propel the market for intravascular ultrasound in the United States during the forecast period.

Europe Intravascular Ultrasound Market Trends

In Europe, the growth of the intravascular ultrasound market is being strongly driven by the rising prevalence of cardiovascular disorders, risk factors such as diabetes, obesity, and high blood pressure across the region thereby boosting the overall market of IVUS market.

According to the data provided by the British Heart Foundation (2024), 7.6 million people are living with heart and circulatory disease. The rising incidence of conditions like atherosclerosis, heart attacks, and strokes is driving the demand for advanced diagnostic tools such as intravascular ultrasound (IVUS), as it provides real-time imaging of coronary arteries and helps in the assessment of plaque buildup, vessel diameter, and stent placement.

Additionally, according to the data provided by the Diabetes UK Organization (2024), in 2023-2024, approximately 5.8 million people in the UK were living with diabetes.

Furthermore, according to the data provided by the Government of UK (2024), 63.8% of adults aged 18 and over were overweight or living with obesity in the United Kingdom.

Moreover, the stats provided by the British Heart Foundation (2025), five million adults in the UK had undiagnosed high blood pressure. Thus, the rising prevalence of risk factors such as diabetes, obesity, and hypertension increases the adoption rate of IVUS-guided interventions to improve procedural outcomes, reduce post-surgical complications, and enhance long-term patient survival rates.

Hence, all the factors mentioned above are expected to drive the market for intravascular ultrasound in the United Kingdom during the forecast period.

Asia-Pacific Intravascular Ultrasound Market Trends

The Asia Pacific region is projectd to grow at a healthy CAGR of 8.86% during the forecast period from 2026 to 2034 and is emerging as a significant growth driver for the intravascular ultrasound market, fueled by rising growing geriatric population and the increasing prevalence of cardiological disorders and associated risk factors.

As per the recent study published in the Journal of National Library of Medicine 2024, it was estimated that approximately 330 million individuals in China are affected by CVD on average.

Among them, there are 13 million cases of stroke, 11.4 million cases of coronary heart disease, 5 million cases of pulmonary heart disease, 8.9 million cases of heart failure, 4.9 million cases of atrial fibrillation, 2.5 million cases of rheumatic heart disease, 2 million cases of congenital heart disease, 45.3 million cases of lower extremity artery disease, and 245 million cases of hypertension.

Additionally, according to the IDF Diabetes Atlas (2024), in 2045, the age-adjusted comparative prevalence of diabetes would increase to 12.6% in China.

As these conditions often involve complex arterial blockages and atherosclerosis, IVUS plays a crucial role in providing high-resolution, real-time imaging of blood vessels, allowing cardiologists to assess plaque burden, vessel size, and lesion characteristics with precision. This enhances the accuracy of percutaneous coronary interventions (PCI) by optimizing stent placement and reducing complications like restenosis and stent thrombosis and thereby boosting the overall market of IUVS.

Who are the major players in the intravascular ultrasound market?

The following are the leading companies in the intravascular ultrasound market. These companies collectively hold the largest market share and dictate industry trends.

  • Koninklijke Philips N.V.
  • Boston Scientific Corporation
  • Terumo Corporation
  • NIPRO
  • CONAVI MEDICAL
  • Bracco
  • Intravascular Imaging Incorporated (i3)
  • Insight Lifetech Co., Ltd.
  • Shanghai Pulse Medical Technology Inc.
  • MicroPort Scientific Corporation
  • Provisio Medical, Inc.
  • Others

How is the competitive landscape shaping the intravascular ultrasound market?

The intravascular ultrasound (IVUS) market is characterized by a moderately to highly concentrated competitive landscape, dominated by a small group of global medtech leaders most notably Boston Scientific, Philips Healthcare, Terumo, and Medtronic which together account for over half of the total market share, driven by their strong cath-lab presence, broad imaging portfolios, and long-standing clinician trust. These players shape competition through continuous product innovation, AI-enabled imaging enhancements, integration with interventional platforms, and strategic acquisitions, reinforcing high entry barriers for new entrants. At the same time, smaller and niche companies compete by focusing on differentiated catheter technologies, hybrid imaging, or cost-effective solutions tailored to specific regions, particularly in emerging markets. As a result, while large incumbents maintain pricing power and scale advantages, ongoing technological advancements and clinical demand for precision-guided interventions ensure the market remains competitive rather than fully consolidated.

Recent Developmental Activities in the Intravascular Ultrasound Market

  • In March 2025, Boston Scientific Corporation announced it has entered into a definitive agreement to acquire SoniVie Ltd., a privately held medical device company that has developed the TIVUS(TM) Intravascular Ultrasound System.
  • In October 2024, MicroPort(R) MicroImaging, a subsidiary of MicroPort Scientific Corporation, obtained approval from the National Medical Products Administration (NMPA) for the marketing of its Decypher(TM) IVUS Diagnostic System and Outsight(R) Disposable IVUS Diagnostic Catheter.
  • In May 2024, Provisio Medical, Inc., announced the completion of the first commercial clinical cases utilizing the Provisio(TM) SLT IVUS(TM) System.
  • In April 2024, Provisio Medical's Provisio(TM) SLT IVUS(TM) System received FDA 510(k) clearance, introducing Sonic Lumen Tomography (SLT) technology for real-time, automatic blood vessel lumen measurement without complex image interpretation. It is the first integrated intravascular imaging and support crossing catheter, enabling simultaneous lumen measurement, visualization, guidewire support, and contrast agent delivery, enhancing vascular procedures.
  • In October 2023, Evident Vascular exits stealth with US$35 million Series A funding to develop intravascular imaging platform.

Intravascular Ultrasound Market Segmentation

  • Intravascular Ultrasound by Type Exposure
  • IVUS Catheters
  • IVUS Consoles
  • Intravascular Ultrasound Application Exposure
  • Coronary Interventions
  • Peripheral Interventions
  • Intravascular Ultrasound End-Users Exposure
  • Hospitals and Clinics
  • Diagnostic Imaging Centers
  • Others
  • Intravascular Ultrasound Geography Exposure
  • North America Intravascular Ultrasound Market
  • United States Intravascular Ultrasound Market
  • Canada Intravascular Ultrasound Market
  • Mexico Intravascular Ultrasound Market
  • Europe Intravascular Ultrasound Market
  • United Kingdom Intravascular Ultrasound Market
  • Germany Intravascular Ultrasound Market
  • France Intravascular Ultrasound Market
  • Italy Intravascular Ultrasound Market
  • Spain Intravascular Ultrasound Market
  • Rest of Europe Intravascular Ultrasound Market
  • Asia-Pacific Intravascular Ultrasound Market
  • China Intravascular Ultrasound Market
  • Japan Intravascular Ultrasound Market
  • India Intravascular Ultrasound Market
  • Australia Intravascular Ultrasound Market
  • South Korea Intravascular Ultrasound Market
  • Rest of Asia-Pacific Intravascular Ultrasound Market
  • Rest of the World Intravascular Ultrasound Market
  • South America Intravascular Ultrasound Market
  • Middle East Intravascular Ultrasound Market
  • Africa Intravascular Ultrasound Market

Impact Analysis

AI-Powered Innovations and Applications:

AI-Powered Innovations and Applications in IVUS are rapidly transforming how intravascular ultrasound is performed and interpreted, moving the technology beyond manual image review toward automated, data-driven clinical decision support. Modern AI algorithms especially deep learning models are being developed to automatically segment lumen, vessel walls, plaque, and stent structures with high accuracy, significantly reducing the need for manual annotation and inter-operator variability during IVUS interpretation. These models can classify vessel components (e.g., calcification or narrow lumina), quantify key anatomical metrics, and assist in lesion characterization, which can improve diagnostic consistency and support treatment planning. AI is also being used to predict procedural outcomes (such as regions affected by rotational atherectomy) and may be extended to broader risk prediction models for adverse cardiovascular events by integrating IVUS imaging with clinical and demographic data. Beyond direct clinical interpretation, AI is accelerating clinician training and proficiency-for example, adaptive educational platforms powered by AI provide personalized, case-based IVUS learning pathways that build pattern recognition and decision-making skills more efficiently. Together, these innovations aim to enhance workflow efficiency, standardize image analysis, and expand the utility and adoption of IVUS in cardiovascular interventions

U.S. Tariff Impact Analysis on Intravascular Ultrasound Market:

The U.S. tariff impact on the Intravascular Ultrasound (IVUS) market reflects broader strains on the U.S. medical device sector caused by recent tariff policies aimed at reshoring manufacturing and reducing dependence on foreign supply chains. Under new trade measures, tariffs of up to double-digit percentages on imported medical devices and components including diagnostic and imaging equipment have been implemented, significantly increasing manufacturing and procurement costs for devices or parts sourced from China, the EU, and other regions, which are crucial suppliers for advanced cardiovascular technologies like IVUS. These heightened duties place margin pressure on both U.S. and foreign IVUS manufacturers, who may face cost-pass-through to hospitals and healthcare providers or absorb higher input costs, potentially slowing adoption in cost-sensitive environments and delaying upgrades of imaging technologies. Supply chain disruptions caused by tariffs make long-established global production networks less efficient, spurring some firms to consider reshoring or diversifying supply bases, but such shifts are costly and time-intensive due to regulatory approvals and manufacturing retooling. Ultimately, tariff-driven cost increases and uncertainty could constrain growth in the U.S. IVUS market by elevating prices, creating procurement challenges for healthcare providers, and dampening demand for cutting-edge imaging modalities unless mitigated by policy adjustments or tariff exemptions for critical medical technologies.

How This Analysis Helps Clients

  • Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
  • Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
  • Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
  • Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.

Key takeaways from the intravascular ultrasound market report study

  • Market size analysis for the current intravascular ultrasound market size (2025), and market forecast for 8 years (2026 to 2034)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the intravascular ultrasound market.
  • Various opportunities available for the other competitors in the intravascular ultrasound market space.
  • What are the top-performing segments in 2025? How these segments will perform in 2034?
  • Which are the top-performing regions and countries in the current intravascular ultrasound market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for the intravascular ultrasound market growth in the future?

Frequently Asked Questions for the Intravascular Ultrasound Market

1. What is the growth rate of the intravascular ultrasound market?

  • The intravascular ultrasound market is estimated to grow at a CAGR of 7.52% during the forecast period from 2026 to 2034.

2. What is the market for intravascular ultrasound?

  • The global intravascular ultrasound market is expected to increase from USD 926.94 million in 2025 to USD 1,774.19 million by 2034.

3. Which region has the highest share in the intravascular ultrasound market?

  • North America is expected to dominate the overall intravascular ultrasound market due to the rising cases of cardiovascular disorders and its risk factors. Additionally, the increasing number of angioplasty procedures across the region is further escalating the market of IVUS.

4. What are the drivers for the intravascular ultrasound market?

  • The market of intravascular ultrasound is being primarily driven by the rising prevalence of cardiovascular diseases (CVDs), driven by risk factors such as aging populations, obesity, diabetes, and hypertension, is significantly boosting the demand for intravascular ultrasound (IVUS) as an essential diagnostic and interventional tool. With the increasing number of percutaneous coronary interventions (PCI) globally, IVUS is being widely adopted to enhance procedural precision, optimize stent deployment, and reduce complications such as restenosis. Additionally, key market players are accelerating growth through strategic acquisitions, partnerships, and R&D investments to develop advanced IVUS technologies, such as high-resolution imaging, 3D IVUS, and AI-driven analysis.

5. Who are the key players operating in the intravascular ultrasound market?

  • Some of the key market players operating in the intravascular ultrasound market include Koninklijke Philips N.V., Boston Scientific Corporation, Terumo Corporation, NIPRO, CONAVI MEDICAL, Bracco, Intravascular Imaging Incorporated (i3), Insight Lifetech Co., Ltd., Shanghai Pulse Medical Technology Inc., MicroPort Scientific Corporation, Provisio Medical, Inc., and others.

Table of Contents

1. Intravascular Ultrasound Market Report Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Segmentation
  • 1.3 Market Assumption

2. Intravascular Ultrasound Market Executive Summary

  • 2.1 Market at Glance

3. Intravascular Ultrasound Market Key Factors Analysis

  • 3.1 Intravascular Ultrasound Market Drivers
    • 3.1.1 Rising prevalence of cardiovascular diseases and associated risk factors
    • 3.1.2 The expanding use of IVUS due to the surge in percutaneous coronary interventions (PCI)
    • 3.1.3 Surging strategic activities such as acquisitions, partnerships, R&D, and others by key market players
  • 3.2 Intravascular Ultrasound Market Restraints and Challenges
    • 3.2.1 Presence of alternatives such as optical coherence tomography (OCT) and advanced angiography
    • 3.2.2 Risk of catheter-related complications
  • 3.3 Intravascular Ultrasound Market Opportunity
    • 3.3.1 Expanding advancements in IVUS such as high-resolution imaging, 3D IVUS, AI analysis, and plaque quantification

4. Impact Analysis

  • 4.1 AI-Powered Innovations and Applications
  • 4.2 U.S. Tariff Impact Analysis

5. Regulatory Analysis

  • 5.1 The United States
  • 5.2 Europe
  • 5.3 Japan
  • 5.4 China

6. Intravascular Ultrasound Market Porter's Five Forces Analysis

  • 6.1 Bargaining Power of Suppliers
  • 6.2 Bargaining Power of Consumers
  • 6.3 Threat of New Entrants
  • 6.4 Threat of Substitutes
  • 6.5 Competitive Rivalry

7. Intravascular Ultrasound Market Assessment

  • 7.1 By Type
    • 7.1.1 IVUS Catheters
    • 7.1.2 IVUS Consoles
  • 7.2 By Application
    • 7.2.1 Coronary Interventions
    • 7.2.2 Peripheral Interventions
  • 7.3 By End-Users
    • 7.3.1 Hospitals and Clinics
    • 7.3.2 Diagnostic Imaging Centers
    • 7.3.3 Others
  • 7.4 By Geography
    • 7.4.1 North America
      • 7.4.1.1 United States Intravascular Ultrasound Market Size in USD million (2023-2034)
      • 7.4.1.2 Canada Intravascular Ultrasound Market Size in USD million (2023-2034)
      • 7.4.1.3 Mexico Intravascular Ultrasound Market Size in USD million (2023-2034)
    • 7.4.2 Europe
      • 7.4.2.1 France Intravascular Ultrasound Market Size in USD million (2023-2034)
      • 7.4.2.2 Germany Intravascular Ultrasound Market Size in USD million (2023-2034)
      • 7.4.2.3 United Kingdom Intravascular Ultrasound Market Size in USD million (2023-2034)
      • 7.4.2.4 Italy Intravascular Ultrasound Market Size in USD million (2023-2034)
      • 7.4.2.5 Spain Intravascular Ultrasound Market Size in USD million (2023-2034)
      • 7.4.2.6 Rest of Europe Intravascular Ultrasound Market Size in USD million (2023-2034)
    • 7.4.3 Asia-Pacific
      • 7.4.3.1 China Intravascular Ultrasound Market Size in USD million (2023-2034)
      • 7.4.3.2 Japan Intravascular Ultrasound Market Size in USD million (2023-2034)
      • 7.4.3.3 India Intravascular Ultrasound Market Size in USD million (2023-2034)
      • 7.4.3.4 Australia Intravascular Ultrasound Market Size in USD million (2023-2034)
      • 7.4.3.5 South Korea Intravascular Ultrasound Market Size in USD million (2023-2034)
      • 7.4.3.6 Rest of Asia-Pacific Intravascular Ultrasound Market Size in USD million (2023-2034)
    • 7.4.4 Rest of the World (RoW)
      • 7.4.4.1 Middle East Intravascular Ultrasound Market Size in USD million (2023-2034)
      • 7.4.4.2 Africa Intravascular Ultrasound Market Size in USD million (2023-2034)
      • 7.4.4.3 South America Intravascular Ultrasound Market Size In USD Million (2023-2034)

8. Competitive Landscape

9. Startup Funding & Investment Trends

10. Intravascular Ultrasound Market Company and Product Profiles

  • 10.1 Koninklijke Philips N.V.
    • 10.1.1 Company Overview
    • 10.1.2 Company Snapshot
    • 10.1.3 Financial Overview
    • 10.1.4 Product Listing
    • 10.1.5 Entropy
  • 10.2 Boston Scientific Corporation
    • 10.2.1 Company Overview
    • 10.2.2 Company Snapshot
    • 10.2.3 Financial Overview
    • 10.2.4 Product Listing
    • 10.2.5 Entropy
  • 10.3 Terumo Corporation
    • 10.3.1 Company Overview
    • 10.3.2 Company Snapshot
    • 10.3.3 Financial Overview
    • 10.3.4 Product Listing
    • 10.3.5 Entropy
  • 10.4 NIPRO
    • 10.4.1 Company Overview
    • 10.4.2 Company Snapshot
    • 10.4.3 Financial Overview
    • 10.4.4 Product Listing
    • 10.4.5 Entropy
  • 10.5 CONAVI MEDICAL
    • 10.5.1 Company Overview
    • 10.5.2 Company Snapshot
    • 10.5.3 Financial Overview
    • 10.5.4 Product Listing
    • 10.5.5 Entropy
  • 10.6 Bracco
    • 10.6.1 Company Overview
    • 10.6.2 Company Snapshot
    • 10.6.3 Financial Overview
    • 10.6.4 Product Listing
    • 10.6.5 Entropy
  • 10.7 Intravascular Imaging Incorporated (i3)
    • 10.7.1 Company Overview
    • 10.7.2 Company Snapshot
    • 10.7.3 Financial Overview
    • 10.7.4 Product Listing
    • 10.7.5 Entropy
  • 10.8 Insight Lifetech Co., Ltd.
    • 10.8.1 Company Overview
    • 10.8.2 Company Snapshot
    • 10.8.3 Financial Overview
    • 10.8.4 Product Listing
    • 10.8.5 Entropy
  • 10.9 Shanghai Pulse Medical Technology Inc.
    • 10.9.1 Company Overview
    • 10.9.2 Company Snapshot
    • 10.9.3 Financial Overview
    • 10.9.4 Product Listing
    • 10.9.5 Entropy
  • 10.10 MicroPort Scientific Corporation
    • 10.10.1 Company Overview
    • 10.10.2 Company Snapshot
    • 10.10.3 Financial Overview
    • 10.10.4 Product Listing
    • 10.10.5 Entropy
  • 10.11 Provisio Medical, Inc.
    • 10.11.1 Company Overview
    • 10.11.2 Company Snapshot
    • 10.11.3 Financial Overview
    • 10.11.4 Product Listing
    • 10.11.5 Entropy

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer & Contact Us

List of Tables

  • Table 1: Intravascular Ultrasound Market in Global (2023-2034)
  • Table 2: Intravascular Ultrasound Market in Global by Type (2023-2034)
  • Table 3: Intravascular Ultrasound Market in Global by Application (2023-2034)
  • Table 4: Intravascular Ultrasound Market in Global by End-Users (2023-2034)
  • Table 5: Intravascular Ultrasound Market in Global by Geography (2023-2034)
  • Table 6: Intravascular Ultrasound Market in North America (2023-2034)
  • Table 7: Intravascular Ultrasound Market in the United States (2023-2034)
  • Table 8: Intravascular Ultrasound Market in Canada (2023-2034)
  • Table 9: Intravascular Ultrasound Market in Mexico (2023-2034)
  • Table 10: Intravascular Ultrasound Market in Europe (2023-2034)
  • Table 11: Intravascular Ultrasound Market in France (2023-2034)
  • Table 12: Intravascular Ultrasound Market in Germany (2023-2034)
  • Table 13: Intravascular Ultrasound Market in United Kingdom (2023-2034)
  • Table 14: Intravascular Ultrasound Market in Italy (2023-2034)
  • Table 15: Intravascular Ultrasound Market in Spain (2023-2034)
  • Table 16: Intravascular Ultrasound Market in the Rest of Europe (2023-2034)
  • Table 17: Intravascular Ultrasound Market in Asia-Pacific (2023-2034)
  • Table 18: Intravascular Ultrasound Market in China (2023-2034)
  • Table 19: Intravascular Ultrasound Market in Japan (2023-2034)
  • Table 20: Intravascular Ultrasound Market in India (2023-2034)
  • Table 21: Intravascular Ultrasound Market in Australia (2023-2034)
  • Table 22: Intravascular Ultrasound Market in South Korea (2023-2034)
  • Table 23: Intravascular Ultrasound Market in Rest of Asia-Pacific (2023-2034)
  • Table 24: Intravascular Ultrasound Market in the Rest of the World (2023-2034)
  • Table 25: Intravascular Ultrasound Market in the Middle East (2023-2034)
  • Table 26: Intravascular Ultrasound Market in Africa (2023-2034)
  • Table 27: Intravascular Ultrasound Market in South America (2023-2034)
  • Table 28: Competitive Landscape
  • Table 29: Startup Funding & Investment Trends

List of Figures

  • Figure 1: Intravascular Ultrasound Market Drivers
  • Figure 2: Intravascular Ultrasound Market Restraints
  • Figure 3: Intravascular Ultrasound Market Opportunities
  • Figure 4: AI-Powered Innovations in Intravascular Ultrasound Market
  • Figure 5: US Tariff Impact on Intravascular Ultrasound Market
  • Figure 6: Regulatory Analysis (US, EU, Japan, China)
  • Figure 7: Porter's Five Forces Analysis
  • Figure 8: Competitive Analysis
  • Figure 9: Intravascular Ultrasound Market in Global (2023-2034)
  • Figure 10: Intravascular Ultrasound Market in Global by Component (2023-2034)
  • Figure 11: Intravascular Ultrasound Market in Global by Application (2023-2034)
  • Figure 12: Intravascular Ultrasound Market in Global by End-Users (2023-2034)
  • Figure 13: Intravascular Ultrasound Market in Global by Geography (2023-2034)
  • Figure 14: Intravascular Ultrasound Market in North America (2023-2034)
  • Figure 15: Intravascular Ultrasound Market in the United States (2023-2034)
  • Figure 16: Intravascular Ultrasound Market in Canada (2023-2034)
  • Figure 17: Intravascular Ultrasound Market in Mexico (2023-2034)
  • Figure 18: Intravascular Ultrasound Market in Europe (2023-2034)
  • Figure 19: Intravascular Ultrasound Market in France (2023-2034)
  • Figure 20: Intravascular Ultrasound Market in Germany (2023-2034)
  • Figure 21: Intravascular Ultrasound Market in United Kingdom (2023-2034)
  • Figure 22: Intravascular Ultrasound Market in Italy (2023-2034)
  • Figure 23: Intravascular Ultrasound Market in Spain (2023-2034)
  • Figure 24: Intravascular Ultrasound Market in the Rest of Europe (2023-2034)
  • Figure 25: Intravascular Ultrasound Market in Asia-Pacific (2023-2034)
  • Figure 26: Intravascular Ultrasound Market in China (2023-2034)
  • Figure 27: Intravascular Ultrasound Market in Japan (2023-2034)
  • Figure 28: Intravascular Ultrasound Market in India (2023-2034)
  • Figure 29: Intravascular Ultrasound Market in Australia (2023-2034)
  • Figure 30: Intravascular Ultrasound Market in South Korea (2023-2034)
  • Figure 31: Intravascular Ultrasound Market in Rest of Asia-Pacific (2023-2034)
  • Figure 32: Intravascular Ultrasound Market in the Rest of the World (2023-2034)
  • Figure 33: Intravascular Ultrasound Market in the Middle East (2023-2034)
  • Figure 34: Intravascular Ultrasound Market in Africa (2023-2034)
  • Figure 35: Intravascular Ultrasound Market in South America (2023-2034)
  • Figure 36: Competitive Landscape
  • Figure 37: Startup Funding & Investment Trends